Download presentation
Presentation is loading. Please wait.
Published byAusten Thompson Modified over 9 years ago
1
Part 2 Lipids & Lipoproteins
2
Lipid and Lipoprotein Population Distributions Serum lipoprotein concentrations differ between adult men and women, Primarily as a result of differences in sex hormone levels, Women having, on average, higher HDL cholesterol levels and lower total cholesterol and triglyceride levels than men. The difference in total cholesterol, however, disappears after menopause as estrogen decreases M. Zaharna Clin. Chem. 2015 2
3
Diagnosis of Lipid Disorders Diseases associated with abnormal lipid concentrations can be caused: directly by genetic abnormalities or through environmental/lifestyle imbalances, or they can develop secondarily, as a consequence of other diseases. Generally defined by the clinical characteristics of patients and the results of laboratory tests Many, but not all, lipid disorders, regardless of etiology, are associated with coronary heart disease (CHD), or arteriosclerosis. M. Zaharna Clin. Chem. 2015 3
4
Arteriosclerosis Deposition of lipids, mainly, esterified cholesterol in artery walls = fatty streaks Small damage to walls - macrophages & platelets move in to repair LDL brings cholesterol for new cell membranes LDL can also be taken up by macrophages = foam cells Accumulation of foam cells deposit in artery walls = fatty streaks Fatty streaks can develop over time into plaques which can partially block or occlude blood flow. M. Zaharna Clin. Chem. 2015 4
5
Arteriosclerosis Increased LDL and decreased HDL associated with increased plaque formation 1% decrease in LDL drops CHD risk 2% Treatment to reduce LDL below 100 mg/dL is effective in the stabilization and sometimes regression of plaques M. Zaharna Clin. Chem. 2015 5
6
Peripheral vascular disease (PVD) When plaque develops in arteries of the arms or legs Coronary artery disease (CAD) when it develops in the heart Cerebrovascular disease (CVD) when it develops in the vessels of the brain M. Zaharna Clin. Chem. 2015 6
7
Adult Reference Ranges For Lipids M. Zaharna Clin. Chem. 2015 7 ANALYTEREFERENCE RANGE Total cholesterol140-200 mg/dL HDL cholesterol40-75 mg/dL LDL cholesterol50-130 mg/dL Triglyceride60-150 mg/dL
8
M. Zaharna Clin. Chem. 2015 8
9
9
10
Cardiac enzyme CK and CK isoenzyme and LD and LD isoenzyme would be useful. Fasting total cholesterol, triglycerides, and HDL and LDL cholesterol could also be performed, but the values should be interpreted with caution because the patient is under stress and may have suffered a MI. The fasting lipids should be repeated after he has been released from the hospital. If he had a MI, it will be approximately 6 weeks before the values represent true levels. M. Zaharna Clin. Chem. 2015 10
11
With a total cholesterol level of approximately 280 mg/dL and normal triglycerides and HDL cholesterol, his LDL cholesterol is estimated to be >190 mg/dL, which is extremely elevated. His physician presumably would have started him on a Step II diet prior to leaving the hospital, based on the in-hospital values. If the 6- to 8-week values do not show significant improvement, the physician would probably start him on medication. The patient has a family history of CHD, and, presumably, the patient has now been diagnosed with CHD. Therefore, the goal would be to reduce LDL cholesterol values to <100 mg/dL. M. Zaharna Clin. Chem. 2015 11
12
Dyslipidemias Dyslipidemia is a disorder of lipoprotein metabolism, Include both the overproduction and deficiency of lipoproteins. Dyslipidemia can manifest as the elevation of plasma cholesterol, triglycerides, or both. It can also be manifested by: the elevation of LDL cholesterol and the decrease of HDL cholesterol in the blood. M. Zaharna Clin. Chem. 2015 12
13
Dyslipidemias Disease states are generally caused by: malfunction in synthesis, transport, or catabolism of lipoproteins Dyslipidemias can be subdivided into two major categories 1. Hyperlipoproteinemia Hypercholesterolemia Hypertriglyceridemia Combined hyperlipoproteinemia 2. Hyolipoproteinemia M. Zaharna Clin. Chem. 2015 13
14
Hypercholesterolemia Familial hypercholesterolemia (FH) Homozygotes rare 1/million Total cholesterol 800-1000 mg/dl Heart attack as early as teenage years Heterozygotes cholesterols 300-600 mg/dl Heart attacks 20-50 years M. Zaharna Clin. Chem. 2015 14
15
Hypercholesterolemia Familial hypercholesterolemia (FH) Primarily LDL elevations Synthesis is normal but decrease or lack LDL receptors Therefore LDL builds-up in serum Since cells cannot acquire from LDL increase internal synthesis M. Zaharna Clin. Chem. 2015 15
16
Hypertriglyceridemia Triglycerides Borderline = 150-200 mg/ dl High 200-500 mg/dl Very High > 500 mg/dl Familial hypertriglyceridemia Genetic Secondary hypertriglyceridemia Hormonal imbalances Imbalance between synthesis and clearance of VLDL M. Zaharna Clin. Chem. 2015 16
17
Hypertriglyceridemia Generally caused by deficiency of LPL or LPL cofactor. LPL hydrolyzes triglycerides in chylomicrons and VLDL Deficiency prevents processing and clearing Elevated even with fasting M. Zaharna Clin. Chem. 2015 17
18
Combined Hyperlipoproteinemia Presence of elevated levels of serum total cholesterol and triglycerides Genetic form of this condition Familial combined hyperlipoproteinemia (FCH) Type III hyperlipoproteinemia an accumulation of cholesterol-rich VLDL and chylomicron remnants as a result of defective catabolism of those particles M. Zaharna Clin. Chem. 2015 18
19
Hypolipoproteinemia Low levels of lipoproteins Hypo alpha or hypobetalipoproteinemias Hypobetalipoproteinemia Associated with low LDL Not associated with CHD M. Zaharna Clin. Chem. 2015 19
20
Hypolipoproteinemia Hypoalphalipoproteinemia Several genetic defects decrease in circulating HDL (<40mg/dl) without hypertriglyceridemia Premature CHD An extreme form -Tangier Disease may have HDL 1-2 mg/dl M. Zaharna Clin. Chem. 2015 20
21
Hypolipoproteinemia Hypoalphalipoproteinemia Acute transient hypoalphalipoproteinemia Severe physiologic stress Infection, surgery, generalized illness Therefore samples taken during hospitalization interpret with caution Return to normal after recovery M. Zaharna Clin. Chem. 2015 21
22
M. Zaharna Clin. Chem. 2015 22
23
Eruptive xanthomas; triglycerides M. Zaharna Clin. Chem. 2015 23 Yes Yes, she has diabetes mellitus. Cessation of estrogen replacement therapy, with consideration of transdermal estrogen therapy, triglyceride- lowering diet and medication, hypoglycemic medication. Most acute risk is pancreatitis.
24
Lipid and Lipoprotein Analyses Lipids and lipoproteins are important indicators of CHD risk, This is the major reason for their measurement in research, as well as in clinical practice. Diagnosis of dyslipidemia is dependent upon the measurement of: 1- Total cholesterol 2- Triglycerides 3- HDL cholesterol 4- and LDL cholesterol M. Zaharna Clin. Chem. 2015 24 Lipid Panel or profile
25
Cholesterol Enzymatic Method Cholesterol esterase cleaves the fatty acid residue from cholesteryl esters, Comprise about two thirds of circulating cholesterol, Converting them to unesterified or free cholesterol. The free cholesterol is reacted by cholesterol oxidase, producing hydrogen peroxide, A common enzymatic color reaction using horseradish peroxidase to couple two colorless chemicals into a colored compound. The intensity of the resulting color, proportional to the amount of cholesterol M. Zaharna Clin. Chem. 2015 25
26
Cholesterol Enzymatic Method M. Zaharna Clin. Chem. 2015 26
27
Several enzymatic reaction sequences are available for triglyceride measurement, All including lipases to cleave fatty acids from the glycerol backbone. The freed glycerol participates in any one of several enzymatic reactions. The last reaction include: conversion of NADH to NAD + Or produce a colored product M. Zaharna Clin. Chem. 2015 27
28
Triglyceride measurement M. Zaharna Clin. Chem. 2015 28 +
29
HDL Methods CDC reference method Three step process Ultracentrifugation to remove VLDL Heparin manganese precipitation to remove LDL activity Then analysis Two-step method with precipitation of non- HDL fractions (apo-B) then analysis on supernatant Enzymatic cholesterol method on remaining M. Zaharna Clin. Chem. 2015 29
30
LDL Methods Friedewald calculation Determine total cholesterol, total triglycerides and HDL as before VLDL is estimated as triglycerides/5 400 mg/dl is the upper limit for TG LDL = Total Cholesterol – HDL – Trig/5 M. Zaharna Clin. Chem. 2015 30
31
Lipoprotein Methods Must separate fractions Electrophoresis – agarose or polyacrylamide Chromatographic Precipitation Ultracentrifugation Immunochemical M. Zaharna Clin. Chem. 2015 31
32
Apolipoprotein Methods Primarily a research method or specialty cardiac service center Usually done by Immunoassay – Turbidimetric ELISA, RIA M. Zaharna Clin. Chem. 2015 32
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.